On Wednesday, Following Stocks were among the “Top 100 Gainers” of U.S. Stock Market: General Mills, Inc. (NYSE:GIS), Oncolytics Biotech Inc. (NASDAQ:ONCY), Energy Transfer Partners, L.P. (NYSE:ETP), Chimera Investment Corporation (NYSE:CIM)

General Mills, Inc. (NYSE:GIS), with shares gained 1.02%, closed at $53.74.

Oncolytics Biotech Inc. (NASDAQ:ONCY), with shares jumped 1.13%, settled at $0.798.

Energy Transfer Partners, L.P. (NYSE:ETP), with shares climbed 0.97%, and closed at $56.29.

Chimera Investment Corporation (NYSE:CIM), surged 0.93%, and closed at $3.27.

Latest NEWS regarding these Stocks are depicted underneath:

General Mills, Inc. (NYSE:GIS)

General Mills, Inc. (GIS), stated results for the third quarter of fiscal 2015.

General Mills Chairman and Chief Executive Officer Ken Powell said, “Our third-quarter results reflect strengthened operating performance. Our U.S. Retail segment posted net sales and profit growth counting contributions from the Annie’s business attained in October 2014. Constant-currency net sales and profit growth accelerated for our International segment. And the Convenience Stores and Foodservice segment led our operating results, with sales up 6 percent and profit up 11 percent.”

Third-quarter net sales of $4.35 billion were 1 percent below year-ago results, as foreign currency exchange reduced net sales growth by 4 percentage points. On a constant-currency basis, net sales grew 3 percent, counting 1 point of growth contributed by the Annie’s attainment. Pound volume was 1 percent below year-ago levels. Net price realization and mix added 4 points of net sales growth. Gross margin was below year-ago levels, primarily reflecting negative product mix and restructuring charges. Selling, general and administrative expenses declined, driven by an 8 percent decrease in advertising and media expense together with cost savings from restructuring actions. Segment operating profit rose 1 percent to $698 million. General Mills posted restructuring and project-related charges totaling $74 million pretax in the third quarter, counting $25 million recorded in cost of sales. (Please see the Corporate Items section below for more information on restructuring actions.) Third-quarter net earnings attributable to General Mills totaled $343 million and diluted EPS totaled 56 cents. Adjusted diluted EPS, which excludes restructuring charges and certain other items affecting comparability, totaled 70 cents, up 13 percent from 62 cents in last year’s third quarter. Foreign currency exchange reduced 2015 third-quarter adjusted diluted EPS by about 1 cent.

General Mills, Inc. manufactures and markets branded consumer foods in the United States and internationally. It also supplies branded and unbranded food products to the foodservice and commercial baking industries. The corporation operates in three segments: U.S. Retail, International, and Convenience Stores and Foodservice.

Oncolytics Biotech Inc. (NASDAQ:ONCY)

Oncolytics Biotech Inc. (ONCY), declared that the European Medicines Agency (“EMA”) has granted Orphan Drug Designation for its lead product candidate, REOLYSIN®, for the treatment of ovarian, fallopian tube and primary peritoneal cancers.

“This is the second jurisdiction where we have gained Orphan Designation for the use of REOLYSIN® in the treatment of these gynecological cancers and our first grant in the European Union,” said Dr. Brad Thompson, President and CEO of Oncolytics. “We continue to secure Orphan Drug Designation for selected cancers as a way to support further development of REOLYSIN® in key jurisdictions globally.”

Oncolytics Biotech Inc., a development stage biopharmaceutical corporation, focuses on the discovery and development of pharmaceutical products for the treatment of cancers. The corporation develops REOLYSIN, a therapeutic reovirus that is in various clinical trials for use as human cancer therapeutic.

Energy Transfer Partners, L.P. (NYSE:ETP)

Sunoco LP (SUN) and Energy Transfer Partners, L.P. (ETP), declared the second dropdown of a portion of ETP’s retail business to SUN.

SUN has agreed to attain from ETP Retail Holdings, an associate of ETP, a 31.58 percent equity interest in Sunoco, LLC, which distributes about 5.3 billion gallons per year of motor fuel to customers in the east, midwest and southeast regions of the U.S. The transaction is valued at about $816 million. SUN will pay $775 million in cash and issue $40.8 million of SUN ordinary units to ETP Retail Holdings, based on the five-day volume-weighted average price of SUN’s ordinary units as of March 20, 2015.

Sunoco, LLC distributes motor fuels across more than 26 states in the east, midwest and southeast regions of the United States to:

• Sunoco Inc. (owned by ETP) for resale at 440 corporation-operated Sunoco and APlus branded convenience stores and other retail fuel outlets.
• 882 Sunoco-branded dealer locations under long-term fuel supply contracts.
• Other fuel distributors of Sunoco-branded fuel that supply an additional 3,640 third-party retail fuel outlets.
• About 400 other commercial customers under spot or short-term contracts.

Energy Transfer Partners, L.P. engages in the natural gas midstream, and intrastate transportation and storage businesses in the United States. The corporation’s Intrastate Transportation and Storage segment transports natural gas from various natural gas producing areas, in addition to through its ET fuel system and HPL system.

Chimera Investment Corporation (NYSE:CIM)

Formerly on March 17, Chimera Investment Corporation (CIM), declared that the Board of Directors has approved a reverse stock split of Chimera’s outstanding shares of ordinary stock at a ratio of 1-for-5, raised the first quarter dividend and set the quarterly dividend for the remainder of 2015.

2015 Dividends:

The Board of Directors of Chimera recently declared the declaration of its first quarter 2015 cash dividend of $0.096 per ordinary share, a 7% raise from the fourth quarter 2014 dividend. The first quarter dividend of $0.096 per ordinary share does not reflect the effect of the reverse stock split and would be equivalent to $0.48 per ordinary share on a reverse stock split 1 for 5 adjusted basis. This dividend is payable April 30, 2015, to ordinary stockholders of record on March 31, 2015. The ex-dividend date is March 27, 2015.

The Board of Directors also declared that it intends to set a consistent quarterly dividend for the second, third and fourth quarters of 2015. After the completion of the reverse stock split, Chimera’s second, third and fourth quarter dividend is each predictable to be set at $0.48 per share on a reverse stock split adjusted basis.

The Corporation distributes dividends based on its current estimate of taxable earnings per ordinary share, not GAAP earnings. Taxable and GAAP earnings will typically differ due to items such as differences in premium amortization, accretion of discounts, unrealized and realized gains and losses, credit loss recognition, and non-deductible general and administrative expenses. Portions of the dividend may be ordinary revenue, capital gains or a return of capital.

Chimera Investment Corporation operates as a real estate investment trust (REIT) in the United States. The corporation, through its auxiliaries, invests in residential mortgage-backed securities (RMBS), residential mortgage loans, commercial mortgage loans, real estate-related securities, and various other asset classes.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.